Achieving Normothermia in Patients with Febrile Subarachnoid Hemorrhage: Feasibility and Safety of a Novel Intravascular Cooling Catheter

Overview

Journal Neurocrit Care

Specialty Critical Care

Date 2005 Sep 22

PMID 16174910

Citations 14

Authors

Neeraj Badjatia

Joan ODonnell

John R Baker

David Huang

Cenk Ayata

David M Greer

Bob S Carter

Christopher S Ogilvy

Colin T McDonald

Affiliations

Soon will be listed here.

Abstract

Introduction: Fever is common and difficult to control in patients with subarachnoid hemorrhage (SAH). We have previously shown an inverse relationship between fever and outcome in patients with SAH.

Materials/methods: This was a prospective, single-arm, feasibility trial in which nine patients with SAH underwent temperature management using an intravascular cooling catheter (ICC) to restore and maintain 24 hours of normothermia (36.5 degrees+/-0.2 degrees C). Enrollment occurred after development of a fever of at least 38.3 degrees C within 7 days of SAH that was refractory to acetaminophen treatment. The ICC was placed at the bedside through an introducer sheath via the femoral vein into the inferior vena cava (IVC). Portable X-ray confirmed placement.

Results: Normothermia was achieved in seven of the nine patients treated (78%); it was achieved in 100% of the patients with a 14F catheter (n=4) and in 60% of the patients with a 9F catheter (n=5). The two patients not reaching normothermia were not adequately treated for shivering. All other patients reached normothermia irrespective of intubation status. Overall, normothermia was well tolerated and not discontinued because of discomfort or adverse events. Two incidences of deep vein thrombosis were diagnosis by ultrasound that were not associated with clinical sequelae, and IVC filters were placed. No unanticipated adverse events occurred.

Discussion: We have demonstrated that fever can be safely and effectively controlled in patients with SAH for at least 24 hours using an ICC. Future studies are needed to assess the effect of such sustained therapy on outcome in patients with SAH.

Citing Articles

In a model of SAH-induced neurogenic fever, BAT thermogenesis is mediated by erythrocytes and blocked by agonism of adenosine A1 receptors.

Tupone D, Cetas J Sci Rep. 2021; 11(1):2752.

PMID: 33531584 PMC: 7854628. DOI: 10.1038/s41598-021-82407-w.

Central Hyperthermia Treated with Bromocriptine.

Natteru P, George P, Bell R, Nattanmai P, Newey C Case Rep Neurol Med. 2017; 2017:1712083.

PMID: 28348904 PMC: 5350322. DOI: 10.1155/2017/1712083.

Effect of a fever control protocol-based strategy on ventilator-associated pneumonia in severely brain-injured patients.

Launey Y, Nesseler N, Le Cousin A, Feuillet F, Garlantezec R, Malledant Y Crit Care. 2014; 18(6):689.

PMID: 25498970 PMC: 4279880. DOI: 10.1186/s13054-014-0689-4.

Early neurological deterioration after subarachnoid haemorrhage: risk factors and impact on outcome.

Helbok R, Kurtz P, Vibbert M, Schmidt M, Fernandez L, Lantigua H J Neurol Neurosurg Psychiatry. 2012; 84(3):266-70.

PMID: 23012446 PMC: 3582083. DOI: 10.1136/jnnp-2012-302804.

Nonpharmacologic approach to minimizing shivering during surface cooling: a proof of principle study.

Shah N, Cowan M, Pickering E, Sareh H, Afshar M, Fox D J Crit Care. 2012; 27(6):746.e1-8.

PMID: 22762936 PMC: 3494806. DOI: 10.1016/j.jcrc.2012.04.016.

References

Albrecht 2nd R, Wass C, Lanier W . Occurrence of potentially detrimental temperature alterations in hospitalized patients at risk for brain injury. Mayo Clin Proc. 1998; 73(7):629-35. DOI: 10.1016/S0025-6196(11)64885-4. View

Johnston S, Selvin S, Gress D . The burden, trends, and demographics of mortality from subarachnoid hemorrhage. Neurology. 1998; 50(5):1413-8. DOI: 10.1212/wnl.50.5.1413. View

Krieger D, De Georgia M, Abou-Chebl A, Andrefsky J, Sila C, Katzan I . Cooling for acute ischemic brain damage (cool aid): an open pilot study of induced hypothermia in acute ischemic stroke. Stroke. 2001; 32(8):1847-54. DOI: 10.1161/01.str.32.8.1847. View

Schmutzhard E, Engelhardt K, Beer R, Brossner G, Pfausler B, Spiss H . Safety and efficacy of a novel intravascular cooling device to control body temperature in neurologic intensive care patients: a prospective pilot study. Crit Care Med. 2002; 30(11):2481-8. DOI: 10.1097/00003246-200211000-00013. View

Globus M, Alonso O, Dietrich W, Busto R, Ginsberg M . Glutamate release and free radical production following brain injury: effects of posttraumatic hypothermia. J Neurochem. 1995; 65(4):1704-11. DOI: 10.1046/j.1471-4159.1995.65041704.x. View

Dippel D, Van Breda E, van Gemert H, van der Worp H, Meijer R, Kappelle L . Effect of paracetamol (acetaminophen) on body temperature in acute ischemic stroke: a double-blind, randomized phase II clinical trial. Stroke. 2001; 32(7):1607-12. DOI: 10.1161/01.str.32.7.1607. View

Broderick J, Brott T, Tomsick T, Miller R, Huster G . Intracerebral hemorrhage more than twice as common as subarachnoid hemorrhage. J Neurosurg. 1993; 78(2):188-91. DOI: 10.3171/jns.1993.78.2.0188. View

Oliveira-Filho J, Ezzeddine M, Segal A, Buonanno F, Chang Y, Ogilvy C . Fever in subarachnoid hemorrhage: relationship to vasospasm and outcome. Neurology. 2001; 56(10):1299-304. DOI: 10.1212/wnl.56.10.1299. View

Clifton G, Miller E, Choi S, Levin H, McCauley S, SMITH Jr K . Lack of effect of induction of hypothermia after acute brain injury. N Engl J Med. 2001; 344(8):556-63. DOI: 10.1056/NEJM200102223440803. View

10.

Marik P . Fever in the ICU. Chest. 2000; 117(3):855-69. DOI: 10.1378/chest.117.3.855. View

11.

Chehrazi B, Giri S, Joy R . Prostaglandins and vasoactive amines in cerebral vasospasm after aneurysmal subarachnoid hemorrhage. Stroke. 1989; 20(2):217-24. DOI: 10.1161/01.str.20.2.217. View

12.

Huang W, Tsai S, Lin M . Involvement of brain glutamate release in pyrogenic fever. Neuropharmacology. 2001; 41(7):811-8. DOI: 10.1016/s0028-3908(01)00120-4. View

13.

Cormio M, Citerio G, Spear S, Fumagalli R, Pesenti A . Control of fever by continuous, low-dose diclofenac sodium infusion in acute cerebral damage patients. Intensive Care Med. 2000; 26(5):552-7. DOI: 10.1007/s001340051203. View

14.

De Witte J, Sessler D . Perioperative shivering: physiology and pharmacology. Anesthesiology. 2002; 96(2):467-84. DOI: 10.1097/00000542-200202000-00036. View

15.

Rousseaux P, Scherpereel B, Bernard M, Graftieaux J, GUYOT J . Fever and cerebral vasospasm in ruptured intracranial aneurysms. Surg Neurol. 1980; 14(6):459-65. View

16.

Clifton G, Allen S, Barrodale P, Plenger P, Berry J, Koch S . A phase II study of moderate hypothermia in severe brain injury. J Neurotrauma. 1993; 10(3):263-71; discussion 273. DOI: 10.1089/neu.1993.10.263. View

17.

Broderick J, Brott T, Tomsick T, Huster G, Miller R . The risk of subarachnoid and intracerebral hemorrhages in blacks as compared with whites. N Engl J Med. 1992; 326(11):733-6. DOI: 10.1056/NEJM199203123261103. View

18.

Giesbrecht G, Sessler D, Mekjavic I, Schroeder M, Bristow G . Treatment of mild immersion hypothermia by direct body-to-body contact. J Appl Physiol (1985). 1994; 76(6):2373-9. DOI: 10.1152/jappl.1994.76.6.2373. View

19.

Jackson R, Mysiw W . Fever of unknown origin following traumatic brain injury. Brain Inj. 1991; 5(1):93-100. DOI: 10.3109/02699059108998518. View

20.

Weir B, Disney L, Grace M, Roberts P . Daily trends in white blood cell count and temperature after subarachnoid hemorrhage from aneurysm. Neurosurgery. 1989; 25(2):161-5. DOI: 10.1097/00006123-198908000-00002. View